3.2. TAT-GILZ Treatment Modulates the Inflammatory Response, Enhances Cell Efferocytosis and Bacterial Clearance in Pneumococcal Pneumonia. This evidence concerns the gene TSC22D3 and pneumococcal pneumonia.